Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Fungaemia in haematological malignancies: SEIFEM-2015 survey.

Criscuolo M, Marchesi F, Candoni A, Cattaneo C, Nosari A, Veggia B, Verga L, Fracchiolla N, Vianelli N, Del Principe MI, Picardi M, Tumbarello M, Aversa F, Busca A, Pagano L; SEIFEM Group (Sorveglianza Epidemiologica Infezioni nelle Emopatie).

Eur J Clin Invest. 2019 Feb 8:e13083. doi: 10.1111/eci.13083. [Epub ahead of print]

PMID:
30735240
2.

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).

Fabiani E, Calabrese C, Niscola P, Balleari E, Molteni A, Finelli C, Falconi G, Fenu S, Fianchi L, Criscuolo M, Salvi F, Lavorgna S, Buccisano F, Maurillo L, Lo Coco F, Cilloni D, Voso MT.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15655. [Epub ahead of print] No abstract available.

PMID:
30407614
3.

Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience.

Metafuni E, Criscuolo M, Spanu T, Sica S.

Ann Hematol. 2018 Nov 1. doi: 10.1007/s00277-018-3535-y. [Epub ahead of print] No abstract available.

PMID:
30387052
4.

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Lindfors Rossi EL, Finelli C, Cerqui E, Ottone T, Molteni A, Parma M, Santarone S, Candoni A, Sica S, Leone G, Lo-Coco F, Voso MT.

Leukemia. 2019 Mar;33(3):785-790. doi: 10.1038/s41375-018-0284-9. Epub 2018 Oct 5. No abstract available.

PMID:
30291338
5.

Therapy-related myeloid neoplasms: clinical perspectives.

Fianchi L, Criscuolo M, Fabiani E, Falconi G, Maraglino AME, Voso MT, Pagano L.

Onco Targets Ther. 2018 Sep 17;11:5909-5915. doi: 10.2147/OTT.S101333. eCollection 2018. Review.

6.

Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes.

Gurnari C, Latagliata R, Buccisano F, Piciocchi A, Fenu S, Mancini S, Fianchi L, Criscuolo M, Sarlo C, Romano A, Falconi G, Niscola P, Di Veroli A, Breccia M, Piccioni A, Aloe-Spiriti MA, Lo-Coco F, Voso MT; GROM-L (Gruppo Romano-Laziale MDS); GROM-L (Gruppo Romano-Laziale MDS).

Leuk Res. 2018 Aug;71:89-91. doi: 10.1016/j.leukres.2018.07.002. Epub 2018 Jul 10. No abstract available.

PMID:
30029156
7.

SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.

Busca A, Cesaro S, Teofili L, Delia M, Cattaneo C, Criscuolo M, Marchesi F, Fracchiolla NS, Valentini CG, Farina F, Di Blasi R, Prezioso L, Spolzino A, Candoni A, Del Principe MI, Verga L, Nosari A, Aversa F, Pagano L; SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Expert Rev Hematol. 2018 Feb;11(2):155-168. doi: 10.1080/17474086.2018.1420472. Epub 2018 Jan 3.

PMID:
29285951
8.

Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome.

Criscuolo M, Fianchi L, Chiusolo P, Giammarco S, Bacigalupo A, Pagano L.

J Clin Immunol. 2018 Jan;38(1):7-9. doi: 10.1007/s10875-017-0467-6. Epub 2017 Dec 1. No abstract available.

PMID:
29196934
9.

Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.

Pagano L, Dragonetti G, Cattaneo C, Marchesi F, Veggia B, Busca A, Candoni A, Prezioso L, Criscuolo M, Cesaro S, Delia M, Fanci R, Stanzani M, Ferrari A, Martino B, Melillo L, Nadali G, Simonetti E, Ballanti S, Picardi M, Castagnola C, Decembrino N, Gazzola M, Fracchiolla NS, Mancini V, Nosari A, Principe MID, Aversa F, Tumbarello M; SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Haematologica. 2017 Oct;102(10):e407-e410. doi: 10.3324/haematol.2017.172536. Epub 2017 Jul 20. No abstract available.

10.

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

Mayer F, Faglioni L, Agabiti N, Fenu S, Buccisano F, Latagliata R, Ricci R, Spiriti MAA, Tatarelli C, Breccia M, Cimino G, Fianchi L, Criscuolo M, Gumenyuk S, Mancini S, Maurillo L, Nobile C, Niscola P, Piccioni AL, Tafuri A, Trapè G, Andriani A, De Fabritiis P, Voso MT, Davoli M, Zini G.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017046. doi: 10.4084/MJHID.2017.046. eCollection 2017.

11.

Treatment of Low-Blast Count AML using Hypomethylating Agents.

De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Review.

12.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S.

Ann Oncol. 2017 Jul 1;28(7):1547-1553. doi: 10.1093/annonc/mdx154.

PMID:
28368509
13.

Managing Formaldehyde indoor pollution in anatomy pathology departments.

d'Ettorre G, Criscuolo M, Mazzotta M.

Work. 2017;56(3):397-402. doi: 10.3233/WOR-172505. Review.

PMID:
28269801
14.

Clonal evolution in therapy-related neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, Hohaus S, Sica S, Postorino M, Neri A, Lionetti M, Leone G, Lo-Coco F, Voso MT.

Oncotarget. 2017 Feb 14;8(7):12031-12040. doi: 10.18632/oncotarget.14509.

15.

Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

Dragonetti G, Criscuolo M, Fianchi L, Pagano L.

Med Mycol. 2017 Jan 1;55(1):82-86. Epub 2016 Dec 2. Review.

PMID:
27915304
16.

Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.

Orlando L, Viale G, Bria E, Lutrino ES, Sperduti I, Carbognin L, Schiavone P, Quaranta A, Fedele P, Caliolo C, Calvani N, Criscuolo M, Cinieri S.

Breast. 2016 Dec;30:151-155. doi: 10.1016/j.breast.2016.09.015. Epub 2016 Oct 14.

PMID:
27750105
17.

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

Buccisano F, Piccioni AL, Nobile C, Criscuolo M, Niscola P, Tatarelli C, Fianchi L, Villivà N, Neri B, Carmosino I, Gumenyuk S, Mancini S, Voso MT, Maurillo L, Breccia M, Zini G, Venditti A, Fenu S, Spiriti MA, Latagliata R; GROM (Gruppo Romano Mielodisplasie).

Ann Hematol. 2016 Jun;95(7):1059-65. doi: 10.1007/s00277-016-2667-1. Epub 2016 Apr 19.

PMID:
27091349
18.

Relative bioavailability between two teriparatide formulations in healthy volunteers.

Farías J, Keller GA, Papouchado M, Villa Etchegoyen MC, Criscuolo ME, Diez RA, Di Girolamo G.

Int J Clin Pharmacol Ther. 2016 Aug;54(8):649-56. doi: 10.5414/CP202562.

PMID:
27007999
19.

Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.

Criscuolo M, Fianchi L, Dragonetti G, Pagano L.

Expert Rev Hematol. 2016;9(2):197-208. doi: 10.1586/17474086.2016.1127156. Epub 2016 Jan 8. Review.

PMID:
26629730
20.

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G.

Exp Hematol. 2016 Jan;44(1):75-83.e1-4. doi: 10.1016/j.exphem.2015.10.005. Epub 2015 Oct 28.

PMID:
26521017
21.

Are adolescents with anorexia nervosa better at reading minds?

Laghi F, Pompili S, Zanna V, Castiglioni MC, Criscuolo M, Chianello I, Baumgartner E, Baiocco R.

Cogn Neuropsychiatry. 2015;20(6):489-501. doi: 10.1080/13546805.2015.1091766. Epub 2015 Oct 14.

PMID:
26465706
22.

How adolescents with anorexia nervosa and their parents perceive family functioning?

Laghi F, Pompili S, Zanna V, Castiglioni MC, Criscuolo M, Chianello I, Mazzoni S, Baiocco R.

J Health Psychol. 2017 Feb;22(2):197-207. doi: 10.1177/1359105315597055. Epub 2016 Jul 10.

PMID:
26253650
23.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Voso MT, Fabiani E, Zang Z, Fianchi L, Falconi G, Padella A, Martini M, Li Zhang S, Santangelo R, Larocca LM, Criscuolo M, La Brocca A, Cutcutache I, Rozen S, Simonetti G, Manfrini M, Martinelli G, Hohaus S, Leone G, Tan P, Tenen DG.

Blood Cancer J. 2015 Jul 3;5:e323. doi: 10.1038/bcj.2015.44. No abstract available.

24.

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Caocci G, Voso MT, Angelucci E, Stauder R, Cottone F, Abel G, Nguyen K, Platzbecker U, Beyne-Rauzy O, Gaidano G, Invernizzi R, Molica S, Criscuolo M, Breccia M, Lübbert M, Sanpaolo G, Buccisano F, Ricco A, Palumbo GA, Niscola P, Zhang H, Fenu S, La Nasa G, Mandelli F, Efficace F.

Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.

PMID:
26120100
25.

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

Voso MT, Niscola P, Piciocchi A, Fianchi L, Maurillo L, Musto P, Pagano L, Mansueto G, Criscuolo M, Aloe-Spiriti MA, Buccisano F, Venditti A, Tendas A, Piccioni AL, Zini G, Latagliata R, Filardi N, Fragasso A, Fenu S, Breccia M; GROM (Gruppo Romano e Laziale MDS) and Basilicata MDS Registry.

Eur J Haematol. 2016 Apr;96(4):344-51. doi: 10.1111/ejh.12595. Epub 2015 Jun 21.

PMID:
26018238
26.

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

Maurillo L, Breccia M, Buccisano F, Voso MT, Niscola P, Trapè G, Tatarelli C, D'Addosio A, Latagliata R, Fenu S, Piccioni AL, Fragasso A, Aloe Spiriti MA, Refrigeri M, Criscuolo M, Musto P, Venditti A.

Eur J Haematol. 2015 Jul;95(1):52-6. doi: 10.1111/ejh.12476. Epub 2015 Mar 12.

PMID:
25764148
27.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.

Fianchi L, Pagano L, Piciocchi A, Candoni A, Gaidano G, Breccia M, Criscuolo M, Specchia G, Maria Pogliani E, Maurillo L, Aloe-Spiriti MA, Mecucci C, Niscola P, Rossetti E, Mansueto G, Rondoni M, Fozza C, Invernizzi R, Spadea A, Fenu S, Buda G, Gobbi M, Fabiani E, Sica S, Hohaus S, Leone G, Voso MT.

Am J Hematol. 2015 May;90(5):E80-5. doi: 10.1002/ajh.23966. Epub 2015 Mar 3.

28.

Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin.

Criscuolo M, Fianchi L, Voso MT, Pagano L.

Br J Haematol. 2015 Mar;168(5):617. doi: 10.1111/bjh.13220. Epub 2014 Nov 18. No abstract available.

PMID:
25403895
29.

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.

Efficace F, Gaidano G, Breccia M, Criscuolo M, Cottone F, Caocci G, Bowen D, Lübbert M, Angelucci E, Stauder R, Selleslag D, Platzbecker U, Sanpaolo G, Jonasova A, Buccisano F, Specchia G, Palumbo GA, Niscola P, Wan C, Zhang H, Fenu S, Klimek V, Beyne-Rauzy O, Nguyen K, Mandelli F.

Br J Haematol. 2015 Feb;168(3):361-70. doi: 10.1111/bjh.13138. Epub 2014 Oct 1.

PMID:
25272332
30.

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Leone G, Voso MT.

Haematologica. 2014 Sep;99(9):e152-3. doi: 10.3324/haematol.2014.108159. Epub 2014 Jun 6. No abstract available.

31.

Why methylation is not a marker predictive of response to hypomethylating agents.

Voso MT, Santini V, Fabiani E, Fianchi L, Criscuolo M, Falconi G, Guidi F, Hohaus S, Leone G.

Haematologica. 2014 Apr;99(4):613-9. doi: 10.3324/haematol.2013.099549. Review.

32.

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

Tatarelli C, Piccioni AL, Maurillo L, Naso V, Battistini R, D'Andrea M, Criscuolo M, Nobile C, Villivà N, Mancini S, Neri B, Breccia M, Fenu S, Buccisano F, Voso MT, Latagliata R, Aloe Spiriti MA.

Ann Hematol. 2014 Aug;93(8):1413-20. doi: 10.1007/s00277-014-2053-9. Epub 2014 Mar 20.

PMID:
24647684
33.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms.

Criscuolo M, Chiusolo P, Giammarco S, Giachelia M, Fianchi L, Fabiani E, Falconi G, Hohaus S, Sica S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Dec;55(12):2942-4. doi: 10.3109/10428194.2014.903475. Epub 2014 Apr 22. No abstract available.

PMID:
24625325
34.

Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.

De Rocco D, Bottega R, Cappelli E, Cavani S, Criscuolo M, Nicchia E, Corsolini F, Greco C, Borriello A, Svahn J, Pillon M, Mecucci C, Casazza G, Verzegnassi F, Cugno C, Locasciulli A, Farruggia P, Longoni D, Ramenghi U, Barberi W, Tucci F, Perrotta S, Grammatico P, Hanenberg H, Della Ragione F, Dufour C, Savoia A; Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.

Haematologica. 2014 Jun;99(6):1022-31. doi: 10.3324/haematol.2014.104224. Epub 2014 Feb 28. Erratum in: Haematologica. 2014 Sep;99(9):1532.

35.

A vinyl chloride-exposed worker with an adrenal gland angiosarcoma: a case report.

Criscuolo M, Valerio J, Gianicolo ME, Gianicolo EA, Portaluri M.

Ind Health. 2014;52(1):66-70. Epub 2013 Dec 2. Review.

36.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.

Fabiani E, Fianchi L, Falconi G, Boncompagni R, Criscuolo M, Guidi F, La Brocca A, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Jul;55(7):1538-43. doi: 10.3109/10428194.2013.845885. Epub 2013 Nov 1.

PMID:
24047476
37.

Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.

Voso MT, Fenu S, Latagliata R, Buccisano F, Piciocchi A, Aloe-Spiriti MA, Breccia M, Criscuolo M, Andriani A, Mancini S, Niscola P, Naso V, Nobile C, Piccioni AL, D'Andrea M, D'Addosio A, Leone G, Venditti A.

J Clin Oncol. 2013 Jul 20;31(21):2671-7. doi: 10.1200/JCO.2012.48.0764. Epub 2013 Jun 24.

PMID:
23796988
38.

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Voso MT, Fabiani E, Fianchi L, Falconi G, Criscuolo M, Santangelo R, Chiusolo P, Betti S, D'Alo' F, Hohaus S, De Stefano V, Leone G.

Leukemia. 2013 Apr;27(4):982-5. doi: 10.1038/leu.2012.267. Epub 2012 Sep 11. No abstract available.

PMID:
22964944
39.

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

Fianchi L, Criscuolo M, Breccia M, Maurillo L, Salvi F, Musto P, Mansueto G, Gaidano G, Finelli C, Aloe-Spiriti A, Santini V, Greco M, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2013 Mar;54(3):658-61. doi: 10.3109/10428194.2012.719617. Epub 2012 Aug 30. No abstract available.

PMID:
22873829
40.

Outcome of therapy-related myeloid neoplasms treated with azacitidine.

Fianchi L, Criscuolo M, Lunghi M, Gaidano G, Breccia M, Levis A, Finelli C, Santini V, Musto P, Oliva EN, Leoni P, Aloe Spiriti A, D'Alò F, Hohaus S, Pagano L, Leone G, Voso MT.

J Hematol Oncol. 2012 Aug 1;5:44. doi: 10.1186/1756-8722-5-44.

41.

High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.

Favaloro L, Diez M, Mendiz O, Janavel GV, Valdivieso L, Ratto R, Garelli G, Salmo F, Criscuolo M, Bercovich A, Crottogini A.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):899-906. doi: 10.1002/ccd.24555. Epub 2013 Jun 5.

PMID:
22777825
42.

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

D'Alò F, Fianchi L, Fabiani E, Criscuolo M, Greco M, Guidi F, Pagano L, Leone G, Voso MT.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011052. doi: 10.4084/MJHID.2011.052. Epub 2011 Nov 28.

43.

Field testing, gene flow assessment and pre-commercial studies on transgenic Solanum tuberosum spp. tuberosum (cv. Spunta) selected for PVY resistance in Argentina.

Bravo-Almonacid F, Rudoy V, Welin B, Segretin ME, Bedogni MC, Stolowicz F, Criscuolo M, Foti M, Gomez M, López M, Serino G, Cabral S, Dos Santos C, Huarte M, Mentaberry A.

Transgenic Res. 2012 Oct;21(5):967-82. doi: 10.1007/s11248-011-9584-9. Epub 2011 Dec 27.

PMID:
22200984
44.

Effect of vascular endothelial growth factor gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after 2 months of coronary artery occlusion.

Vera Janavel GL, De Lorenzi A, Cortés C, Olea FD, Cabeza Meckert P, Bercovich A, Criscuolo M, Laguens R, Crottogini A.

J Gene Med. 2012 Apr;14(4):279-87. doi: 10.1002/jgm.1608.

PMID:
21954009
45.

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule.

Voso MT, Fianchi L, Criscuolo M, Greco M, D'Alo F, Hohaus S, Pagano L, Leone G.

Leuk Res. 2012 Jan;36(1):e15-7. doi: 10.1016/j.leukres.2011.08.010. Epub 2011 Sep 9. No abstract available.

PMID:
21907408
46.

p57(Kip2) and cancer: time for a critical appraisal.

Borriello A, Caldarelli I, Bencivenga D, Criscuolo M, Cucciolla V, Tramontano A, Oliva A, Perrotta S, Della Ragione F.

Mol Cancer Res. 2011 Oct;9(10):1269-84. doi: 10.1158/1541-7786.MCR-11-0220. Epub 2011 Aug 4. Review.

47.

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.

Voso MT, Fabiani E, Piciocchi A, Matteucci C, Brandimarte L, Finelli C, Pogliani E, Angelucci E, Fioritoni G, Musto P, Greco M, Criscuolo M, Fianchi L, Vignetti M, Santini V, Hohaus S, Mecucci C, Leone G.

Leukemia. 2011 Dec;25(12):1910-3. doi: 10.1038/leu.2011.170. Epub 2011 Jul 15. No abstract available.

PMID:
21760590
48.

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.

Greco M, Criscuolo M, Fianchi L, Fabiani E, Pagano L, Voso M.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011011. doi: 10.4084/MJHID.2011.011. Epub 2011 Mar 15.

49.

Targeting p27Kip1 protein: its relevance in the therapy of human cancer.

Borriello A, Bencivenga D, Criscuolo M, Caldarelli I, Cucciolla V, Tramontano A, Borgia A, Spina A, Oliva A, Naviglio S, Della Ragione F.

Expert Opin Ther Targets. 2011 Jun;15(6):677-93. doi: 10.1517/14728222.2011.561318. Epub 2011 Feb 28. Review.

PMID:
21355788
50.

Primary plasma cell leukemia followed by testicular plasmacytoma.

Valentini CG, Bozzoli V, Fianchi L, Voso MT, Di Paolantonio G, Criscuolo M, Leone G, Larocca LM, Pagano L.

Int J Hematol. 2011 Feb;93(2):224-227. doi: 10.1007/s12185-010-0745-z. Epub 2011 Jan 13.

PMID:
21229400

Supplemental Content

Loading ...
Support Center